Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 1,565 shares at $144.06 ($226K) on 2021-03-22, disclosed to the SEC on 2021-03-23.
Open-market sale of $226k MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.83 | 255 | $36K | 16.1% |
| 2 | $144.06 | 366 | $53K | 23.3% |
| 3 | $144.06 | 366 | $53K | 23.3% |
| 4 | $145.47 | 227 | $33K | 14.6% |
| 5 | $146.46 | 290 | $42K | 18.8% |
| 6 | $147.50 | 61 |
| $9K |
| 4.0% |
| Total | $144.64 avg | 1,565 | $226K | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |